These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 19040997)

  • 1. Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism.
    Trunzo JA; McHenry CR; Schulak JA; Wilhelm SM
    Surgery; 2008 Dec; 144(6):915-8; discussion 919. PubMed ID: 19040997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis.
    Chow TL; Chan TT; Ho YW; Lam SH
    Arch Surg; 2007 Jul; 142(7):644-8. PubMed ID: 17638802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
    Fujita Y; Inoue S; Horiguchi S; Kuki A
    Miner Electrolyte Metab; 1995; 21(1-3):50-4. PubMed ID: 7565462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four gland parathyroidectomy without reimplantation in patients with chronic renal failure.
    Saunders RN; Karoo R; Metcalfe MS; Nicholson ML
    Postgrad Med J; 2005 Apr; 81(954):255-8. PubMed ID: 15811891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients?
    Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
    Nephrology (Carlton); 2006 Oct; 11(5):394-9. PubMed ID: 17014551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Septicemia in patients with ESRD is associated with decreased hematocrit and increased use of erythropoietin.
    Nissenson AR; Dylan ML; Griffiths RI; Yu HT; Dubois RW
    Clin J Am Soc Nephrol; 2006 May; 1(3):505-10. PubMed ID: 17699252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 12-week clinical effects of erythropoietin espogen in end stage renal patients undergoing hemodialysis.
    Thitiarchakul S; Tasanarong A
    J Med Assoc Thai; 2007 Apr; 90(4):636-42. PubMed ID: 17487116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spermatogenesis after parathyroidectomy in patients with symptomatic secondary hyperparathyroidism.
    Chou FF; Lee CH; Lee CT; Huang FJ; Hsu KL
    J Am Coll Surg; 2003 Jun; 196(6):854-8. PubMed ID: 12788420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical treatment of secondary hyperparathyroidism in chronic renal failure. Report of 57 cases].
    Sayad H; Jai SR; Ahazzam J; Lakhloufi A; Chihab F; Bouzidi A; Aghai R; Tarass F; Ramdani B; Hachim K; Benghanem NG; Zaid D
    Tunis Med; 2008 Feb; 86(2):140-3. PubMed ID: 18444530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of surgical parathyroidectomy for secondary hyperparathyroidism in renal dialysis patients in Qatar.
    Rashed A; Fahmi M; ElSayed M; Aboud O; Asim M
    Transplant Proc; 2004; 36(6):1815-7. PubMed ID: 15350484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-operative parathyroid hormone monitoring in secondary hyperparathyroidism: is it useful?
    Roshan A; Kamath B; Roberts S; Atkin SL; England RJ
    Clin Otolaryngol; 2006 Jun; 31(3):198-203. PubMed ID: 16759239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of anemia in renal transplantation: impact of a stricter application of hemoglobin targets.
    Gentil MA; Pérez-Valdivia MA; González-Roncero FM; López-Mendoza M; Cabello V; Bernal G; Suñer M; Pereira P
    Transplant Proc; 2008 Nov; 40(9):2916-8. PubMed ID: 19010146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is anemia of chronic renal failure related to secondary hyperparathyroidism?
    Podjarny E; Rathaus M; Korzets Z; Blum M; Zevin D; Bernheim J
    Arch Intern Med; 1981 Mar; 141(4):453-5. PubMed ID: 7212887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperparathyroidism: a seven-year follow-up.
    Juergensen PH; Cooper K; Kliger AS; Finkelstein FO
    Adv Perit Dial; 1998; 14():188-90. PubMed ID: 10649721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management.
    Mittendorf EA; Merlino JI; McHenry CR
    Am Surg; 2004 Feb; 70(2):114-9; discussion 119-20. PubMed ID: 15011912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary hyperparathyroidism as cause of resistance to treatment with erythropoietin: effect of parathyroidectomy.
    Goicoechea M; Gomez-Campdera F; Polo JR; Tejedor A; Ruiz MA; Vazquez I; Verde E; Valderrabano F
    Clin Nephrol; 1996 Jun; 45(6):420-1. PubMed ID: 8793241
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.
    Rao DS; Shih MS; Mohini R
    N Engl J Med; 1993 Jan; 328(3):171-5. PubMed ID: 8417383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive changes after parathyroidectomy in patients with secondary hyperparathyroidism.
    Chou FF; Chen JB; Hsieh KC; Liou CW
    Surgery; 2008 Apr; 143(4):526-32. PubMed ID: 18374050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing hospitalizations of end-stage renal disease patients on dialysis and inpatient utilization of erythropoiesis-stimulating agent therapy.
    Brophy DF; Daniel G; Gitlin M; Mayne TJ
    Ann Pharmacother; 2010 Jan; 44(1):43-9. PubMed ID: 20028955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients.
    Lin CL; Hung CC; Yang CT; Huang CC
    Ren Fail; 2004 May; 26(3):289-95. PubMed ID: 15354979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.